Clinical Trials Directory

Trials / Completed

CompletedNCT06290739

A Machine-learning Model to Predict Lymph Node Metastasis of Intrahepatic Cholangiocarcinoma

Development and Validation of a Machine-learning Model to Predict Lymph Node Metastasis of Intrahepatic Cholangiocarcinoma: a Retrospective Cohort Study.

Status
Completed
Phase
Study type
Observational
Enrollment
483 (actual)
Sponsor
West China Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The object of this study is to develop a model for prediction of lymph node metastasis among intrahepatic cholangiocarcinoma (ICC) patients. Intrahepatic cholangiocarcinoma is the second most common kind of primary liver cancer, accounting for approximately 10%-15%. There is a lack of agreement regarding the necessity of performing lymph node dissection (LND) in patients with ICC. Currently, the percentage of LND is below 50%, and the rate of sufficient LND (≥6) has plummeted to less than 20%. Consequently, a large proportion of patients are unable to acquire LN status, which hinders the following systematic treatment strategies after surgery:. Therefore, our objective is to construct a LN metastasis model utilizing machine learning techniques, including patients' clinical data and pathology information, with the goal of offering a reference for patients who have not undergone LND or have had inadequate LND.

Conditions

Interventions

TypeNameDescription
PROCEDURElymph nodes dissectionWhether lymph nodes dissection should be performed on curative-intent hepatectomy for intrahepatic cholangiocarcinoma is still debated.

Timeline

Start date
2024-02-07
Primary completion
2024-11-20
Completion
2024-11-20
First posted
2024-03-04
Last updated
2024-11-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06290739. Inclusion in this directory is not an endorsement.